Skip to main content

Psoriatic arthritis

      RT @RichardPAConway: Guselkumab improves anaemia in PsA. Appears to correlate with CRP response, ie inflammatory effect.

      Richard Conway RichardPAConway

      4 years 1 month ago
      Guselkumab improves anaemia in PsA. Appears to correlate with CRP response, ie inflammatory effect. Anaemia resolution associated good outcomes, but many with good outcomes still anaemic. Abstr#1331 #ACR21 @RheumNow https://t.co/LL63Qc0nk5
      RT @swethaann23: Study on enthesitis response to biologic Rx

      ⭐️TNFI caused a 2❎ 🔽mean ActiveMASEI score compar

      swethaann23 swethaann23

      4 years 1 month ago
      Study on enthesitis response to biologic Rx ⭐️TNFI caused a 2❎ 🔽mean ActiveMASEI score compared to secukinumab ⭐️ 🔽PASI and DLQI score more in TNFI than Secukinumab 🔰Superiority of TNFi versus secukinumab in regards to active enthesitis Abst#1356 #ACR21 @Rheumnow https://t.co/wdzMYmn8AJ
      RT @RichardPAConway: Dr Elliott presenting on US assessment of enthesitis with TNFi vs secukinumab. Surprisingly TNFi sh

      Richard Conway RichardPAConway

      4 years 1 month ago
      Dr Elliott presenting on US assessment of enthesitis with TNFi vs secukinumab. Surprisingly TNFi showed a more marked decrease in US enthesitis. Abstr#1356 #ACR21 @RheumNow https://t.co/XXgYMgkMyP
      RT @RichardPAConway: Guselkumab (IL23p19 inhibitor) positive effect on axial outcomes in PsA, durable response across 2

      Richard Conway RichardPAConway

      4 years 1 month ago
      Guselkumab (IL23p19 inhibitor) positive effect on axial outcomes in PsA, durable response across 2 years. Abstr#1330 #ACR21 @RheumNow https://t.co/8LOSdzCvRc
      RT @synovialjoints: A meta-analysis of 5 cohort studies showed that PsA is significantly associated with vertebral fract

      Dr. Antoni Chan synovialjoints

      4 years 1 month ago
      A meta-analysis of 5 cohort studies showed that PsA is significantly associated with vertebral fractures pooled OR 2.09 (95% CI, 1.11 – 3.96; I2 70%). The review was not suggestive of publication bias @RheumNow #ACR21 Abst#1304 https://t.co/rjC776FXUA https://t.co/QvMWxN6ZZ7
      RT @RichardPAConway: Meta-analysis shows increased risk of vertebral fracture in PsA, OR 2.09. Abstr#1304 #ACR21 @RheumN

      Richard Conway RichardPAConway

      4 years 1 month ago
      Meta-analysis shows increased risk of vertebral fracture in PsA, OR 2.09. Abstr#1304 #ACR21 @RheumNow https://t.co/kTrR7I3HA0
      RT @swethaann23: Minimal disease activity achievement in PsA achieved by 22.8% in 6 mo of b/ts DMARD

      MDA achievers were

      swethaann23 swethaann23

      4 years 1 month ago
      Minimal disease activity achievement in PsA achieved by 22.8% in 6 mo of b/ts DMARD MDA achievers were: ➡️Younger ➡️🔽 Disease duration; ➡️ Male ➡️Non-obese ➡️bDMARD-naïve at baseline ➡️🔼 probability achieving MDA components➕MCID PROMs at 6 mo Abst# 1344 #ACR21 @Rheumnow
      RT @RichardPAConway: Effect of BMI on PRO treatment response in PsA. Increasing BMI associated with lower response. More

      Richard Conway RichardPAConway

      4 years 1 month ago
      Effect of BMI on PRO treatment response in PsA. Increasing BMI associated with lower response. More pronounced in TNFi than IL-17 or JAKi. Abstr#1327 #ACR21 @RheumNow https://t.co/qhgVlW72uM
      The RheumNow faculty reporters have been scouring and reporting on the best abstracts from the ACR. Here is a sampling of their choice abstract presentations reported during ACR 2020 Day 2 (#ACRbest).
      RT @_Castillo_Pedro: AS and PsA: Mortality vs Gen Pop (meta-analysis)
      AS:
      👉⬆️All-cause
      👉⬆️CVD
      PsA:
      👉All

      Pedro Castillo _Castillo_Pedro

      4 years 1 month ago
      AS and PsA: Mortality vs Gen Pop (meta-analysis) AS: 👉⬆️All-cause 👉⬆️CVD PsA: 👉All-cause not higher 👉⬆️CVD, Respiratory, and Infectious etiologies Important to consider CVD and other comorbidities. https://t.co/9K4qNpYvMb #ACR21 Abst#0569 @RheumNow
      ×